1. P27 Evaluation and baseline characteristics of patients with chronic thromboembolic disease in a single referral centre. (15th November 2016) Authors: Swietlik, EM; Taboada, D; Ruggiero, A; Bales, E; Harlow, L; Fletcher, A; Cannon, JE; Sheares, K; Jenkins, DP; Pepke-Zaba, J; Toshner, M Journal: Thorax Issue: Volume 71(2016)Supplement 3 Page Start: A97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P29 Exercise intolerance in chronic thromboembolic disease: evaluation, underlying mechanisms and clinical implications. (15th November 2016) Authors: Swietlik, EM; Taboada, D; Ruggiero, A; Bales, E; Harlow, L; Fletcher, A; Cannon, JE; Sheares, K; Jenkins, DP; Pepke-Zaba, J; Toshner, T Journal: Thorax Issue: Volume 71(2016)Supplement 3 Page Start: A98 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P183 Impact of patient choice on survival in patients with chronic thromboembolic pulmonary hypertension offered pulmonary endarterectomy. (15th November 2017) Authors: Quadery, SR; Swift, AJ; Billings, C; Thompson, AAR; Elliot, CA; Hurdman, J; Garrod, S; Charalampopolous, A; Sabroe, I; Armstrong, I; Hamilton, N; Sephton, P; Lewis, RA; Prasannan, P; Jenkins, DP; Pepke-Zaba, J; Screaton, N; Lawrie, A; Johns, CS; Rajaram, S Journal: Thorax Issue: Volume 72(2017)Supplement 3 Page Start: A181 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Communicating future overheating risks to building design practitioners: Using the Low Carbon Futures tool. (March 2015) Authors: Gul, Mehreen Saleem; Jenkins, DP; Patidar, S; Menzies, GF; Banfill, PFG; Gibson, GJ Other Names: Mylona A guest-editor.; Davies M guest-editor. Journal: Building services engineering research & technology Issue: Volume 36:Number 2(2015) Page Start: 182 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. NS6180, a new KCa3.1 channel inhibitor prevents T‐cell activation and inflammation in a rat model of inflammatory bowel disease. (20th December 2012) Authors: Strøbæk, D; Brown, DT; Jenkins, DP; Chen, Y‐J; Coleman, N; Ando, Y; Chiu, P; Jørgensen, S; Demnitz, J; Wulff, H; Christophersen, P Journal: British journal of pharmacology Issue: Volume 168:Number 2(2013:Jan.) Page Start: 432 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. NS6180, a new KCa3.1 channel inhibitor prevents T‐cell activation and inflammation in a rat model of inflammatory bowel disease. (20th December 2012) Authors: Strøbæk, D; Brown, DT; Jenkins, DP; Chen, Y‐J; Coleman, N; Ando, Y; Chiu, P; Jørgensen, S; Demnitz, J; Wulff, H; Christophersen, P Journal: British journal of pharmacology Issue: Volume 168:Number 2(2013:Jan.) Page Start: 432 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗